Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Optic Neuropathy, Ischemic

• Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA
• Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
• NAION Treatment With Oral Prednisolone and Erythropoietin Injection
• Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
• Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery
• Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy
• A Phase I Clinical Trial of DARC
• ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
• Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION
• Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).
• A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Effect of EECP on Anterior Ischemic Optic Neuropathy
• Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
• NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
• Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
• Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
• PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
• Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
• A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
• Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
• Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
• Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases